Titan executes agreement for acquisition by Molteni of Probuphine® in Europe
Titan Pharmaceuticals announced it has entered into a definitive asset purchase, supply and support agreement with L. Molteni through which Molteni has acquired the European intellectual property related to Probuphine, including the MAA under review by the EMA. March 21, 2018